ASX - By Stock
|
IMM |
Re:
IMM CHART / SP
|
|
Hodgie28
|
213 |
89K |
14 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
213
|
89K
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
Hodgie28
|
108 |
44K |
4 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
108
|
44K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Hodgie28
|
743 |
340K |
10 |
07/11/21 |
07/11/21 |
ASX - By Stock
|
743
|
340K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Hodgie28
|
743 |
340K |
9 |
07/11/21 |
07/11/21 |
ASX - By Stock
|
743
|
340K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
IMM CHART / SP
|
|
Hodgie28
|
213 |
89K |
24 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
213
|
89K
|
24
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Hodgie28
|
14K |
6.7M |
10 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
14K
|
6.7M
|
10
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Hodgie28
|
33K |
16M |
12 |
03/11/21 |
03/11/21 |
Charts
|
33K
|
16M
|
12
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Receives Positive EMA Scientific Advice For Further Clinical Development Of EFTI...
|
|
Hodgie28
|
25 |
10K |
10 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
25
|
10K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Receives Positive EMA Scientific Advice For Further Clinical Development Of EFTI...
|
|
Hodgie28
|
25 |
10K |
11 |
02/11/21 |
02/11/21 |
ASX - By Stock
|
25
|
10K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives EMA scientific advice for Phase 3 in MBC
|
|
Hodgie28
|
24 |
9.4K |
13 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
24
|
9.4K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
IMM CHART / SP
|
|
Hodgie28
|
213 |
89K |
11 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
213
|
89K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
IMM CHART / SP
|
|
Hodgie28
|
213 |
89K |
7 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
213
|
89K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
CLSA initiate on Immutep with Target price of $1.19
|
|
Hodgie28
|
35 |
20K |
21 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
35
|
20K
|
21
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Hodgie28
|
743 |
340K |
10 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
743
|
340K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Hodgie28
|
743 |
340K |
11 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
743
|
340K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Hodgie28
|
743 |
340K |
21 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
743
|
340K
|
21
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Hodgie28
|
743 |
340K |
22 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
743
|
340K
|
22
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Hodgie28
|
14K |
6.7M |
33 |
14/10/21 |
14/10/21 |
ASX - By Stock
|
14K
|
6.7M
|
33
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Hodgie28
|
33K |
16M |
12 |
14/10/21 |
14/10/21 |
Charts
|
33K
|
16M
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Corporate Presentation
|
|
Hodgie28
|
29 |
11K |
14 |
30/09/21 |
30/09/21 |
ASX - By Stock
|
29
|
11K
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Corporate Presentation
|
|
Hodgie28
|
29 |
11K |
25 |
30/09/21 |
30/09/21 |
ASX - By Stock
|
29
|
11K
|
25
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Corporate Presentation
|
|
Hodgie28
|
29 |
11K |
17 |
29/09/21 |
29/09/21 |
ASX - By Stock
|
29
|
11K
|
17
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Corporate Presentation
|
|
Hodgie28
|
29 |
11K |
16 |
29/09/21 |
29/09/21 |
ASX - By Stock
|
29
|
11K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Hodgie28
|
743 |
340K |
20 |
19/09/21 |
19/09/21 |
ASX - By Stock
|
743
|
340K
|
20
|
|
ASX - By Stock
|
IMU |
Re:
Interpretation of the so far published mOS and mPFS data on HER-VAXX trial
|
|
Hodgie28
|
43 |
25K |
7 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
43
|
25K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials
|
|
Hodgie28
|
345 |
169K |
11 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
345
|
169K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials
|
|
Hodgie28
|
345 |
169K |
12 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
345
|
169K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Appendix 4E & 2021 Full Year Statutory Accounts
|
|
Hodgie28
|
15 |
6.0K |
7 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
15
|
6.0K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep's partner, EOC Pharma, expands efti trial pipeline
|
|
Hodgie28
|
9 |
8.8K |
7 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
9
|
8.8K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
ESMO 2021
|
|
Hodgie28
|
128 |
48K |
18 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
128
|
48K
|
18
|
|
ASX - By Stock
|
IMM |
Re:
ESMO 2021
|
|
Hodgie28
|
128 |
48K |
3 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
128
|
48K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
ESMO 2021
|
|
Hodgie28
|
128 |
48K |
19 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
128
|
48K
|
19
|
|
ASX - By Stock
|
IMM |
Re:
Ann: 2021 EGM Presentation
|
|
Hodgie28
|
49 |
16K |
5 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
49
|
16K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
In LC and PH we trust.....
|
|
Hodgie28
|
37 |
17K |
9 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
37
|
17K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Ann: 2021 EGM Presentation
|
|
Hodgie28
|
49 |
16K |
19 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
49
|
16K
|
19
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Change in substantial holding
|
|
Hodgie28
|
23 |
7.5K |
28 |
25/07/21 |
25/07/21 |
ASX - By Stock
|
23
|
7.5K
|
28
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Capital Raising Presentation
|
|
Hodgie28
|
210 |
89K |
12 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
210
|
89K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Efti to be evaluated in new triple combination therapy trial
|
|
Hodgie28
|
29 |
14K |
8 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
29
|
14K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Efti to be evaluated in new triple combination therapy trial
|
|
Hodgie28
|
29 |
14K |
22 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
29
|
14K
|
22
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Hodgie28
|
157 |
69K |
15 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
157
|
69K
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Hodgie28
|
157 |
69K |
10 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
157
|
69K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Hodgie28
|
157 |
69K |
11 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
157
|
69K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep achieves Fast Track designation for Efti from US FDA
|
|
Hodgie28
|
68 |
44K |
12 |
11/06/21 |
11/06/21 |
ASX - By Stock
|
68
|
44K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep presentation for Jefferies Healthcare Conference
|
|
Hodgie28
|
140 |
54K |
19 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
140
|
54K
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Proposed issue of Securities - IMU
|
|
Hodgie28
|
24 |
8.9K |
11 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
24
|
8.9K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Appendix 2A
|
|
Hodgie28
|
18 |
5.6K |
20 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
18
|
5.6K
|
20
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Reveals a New anti-LAG-3 Research Program
|
|
Hodgie28
|
32 |
13K |
31 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
32
|
13K
|
31
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep presentation for Jefferies Healthcare Conference
|
|
Hodgie28
|
140 |
54K |
28 |
06/06/21 |
06/06/21 |
ASX - By Stock
|
140
|
54K
|
28
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Secures Second European Patent For Eftilagimod Alpha, A Soluble Lag-3 Protein, In...
|
|
Hodgie28
|
86 |
30K |
13 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
86
|
30K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
IMM CHART / SP
|
|
Hodgie28
|
213 |
89K |
13 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
213
|
89K
|
13
|
|